New AACR data highlight stenoparib’s potential in colorectal cancer through WNT pathway modulationThe Stenoparib-DRP® companion ...
Iterion Therapeutics announced that two abstracts featuring its first-in-class TBL1 inhibitor, tegavivint, will be presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting.
7d
This laser breakthrough supercharges osteoporosis treatment by exposing bone's hidden growth switch
A research team has discovered a new mechanism and drug combination strategy that can effectively treat osteoporosis, a ...
Seoul National University College of Engineering (SNU Engineering) announced that a joint research team led by Prof. Sunghoon ...
Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether ...
Brain organoids reveal that two genetic mutations in DEPDC5 drive epilepsy, disrupting early brain development, and causing ...
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, ...
Morning Overview on MSN
Researchers find some cancer drugs work differently than their stated targets
As of spring 2026, a cancer drug that has spent years in clinical development as a Wnt/beta-catenin pathway blocker has been ...
Why does the same genetic mutation cause a severe brain malformation in some patients but not in others? Researchers from the ...
Cancer stem cells (CSCs), a critical subpopulation within tumors, drive cancer initiation, progression, metastasis, relapse, and resistance to therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results